NCT06767241View on ClinicalTrials.gov

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2022

Conditions

COVID-19

Interventions

DEVICE

Non-invasive auricular vagus nerve stimulation

Non-invasive transcranial direct current auricular vagus nerve stimulation (tDC-aVNS)

OTHER

Standard Medical Therapy

Standard of care treatment for moderate to severe COVID-19

Trial Locations (1)

300310

Infectious Diseases and Pulmonology Clinical Hospital Timisoara, Timișoara

All Listed Sponsors

lead

"University of Medicine and Pharmacy Victor Babes Timisoara"

OTHER

NCT06767241 - Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients | Biotech Hunter | Biotech Hunter